Gender based assessment of 10 year cardiovascular risk in hypertensive patients
Journal Title: International Journal of Research in Pharmacology & Pharmacotherapeutics (IJRPP) - Year 2015, Vol 4, Issue 3
Abstract
BACKGROUND Cardiovascular disease develops 7 to 10 years later in women than in men and is still the major cause of death in women. The risk of heart disease in women is often underestimated due to the misperception that females are ‘protected’ against cardiovascular disease. AIM To determine 10 year cardiovascular risk in hypertensive patients of either sex with emphasis on specific risk factors predisposing to morbidity and mortality from cardiovascular disease in both sexes. MATERIALS AND METHODS This cross-sectional observational study was conducted in the Cardiology outpatient department (OPD) at Rajindra Hospital, Patiala. A total of 150 patients were included in the study. The data pertaining to four risk factors-ages, smoking history, blood pressure and serum cholesterol level was collected from all the patients. Data collected was used to calculate 10 year risk of morbidity and mortality from cardiovascular disease by using Framingham Risk Score. RESULTS In the present study patients were in the age group of 35-60 years and out of 150 patients 85 were females and 65 were males. It was observed that serum cholesterol was in borderline range in 46.15% of females and 29.4% of males whereas raised serum cholesterol levels were observed in 23.5% females and 15.38% males. 52.9% of females and 92.3% of males were having stage 1 hypertension and stage 2 hypertension was risk factor in 47.05% of females and 23.07% of males. Smoking history was present in 4.7% of females and 61.5% of males. According to Framingham Heart Score, 8.2% of females and 26.15% males were in low risk category (calculated risk<10%). Moderate risk (calculated risk between 10-20%) was observed in 35.29% females and 33.84% males whereas high risk (calculated score more than 20%) was observed in 56.4% females and 55.38% males.
Authors and Affiliations
Payal preet
Keywords
Related Articles
- EP ID EP410903
- DOI -
- Views 134
- Downloads 0
Role of clinical pharmacist in reporting medication errors
Aim The aim of the study is to assess the medication errors in a secondary care hospital. A medication error is a failure in the treatment process that leads to, or has the potential to lead to, harm to the patient. Fur...
An overview on the national burden of tuberculosis and its current status
Tuberculosis (TB) still remain a major challenging global health problem. India is one the high TB burden country, adding to 26 per cent of the worldwide TB burden. During the 20th century, TB became treatable and the...
Standardization of siddha formulation ‘Pereechangai Nei’ – medicated ghee of date fruit
Drug standardization of herbal formulations is essential for their acceptance in this scientific medical world. In this article Physicochemical, Phytochemical and other standardization methods of one such polyherbal medi...
A review on AKT1 and PTEN gene of proteus syndrome
Proteus syndrome is a very complex and rare to find in the world. It consists of asymmetric and disproportionate overgrowth in bones and skins. There are very few cases that have been come in light all over the world. Th...
Hyperbilirubinemia during Atazanavir treatment in HIV/AIDS patients taking second line ART drugs
Background Hyperbilirubinemia is frequently observed in HIV (Human Immunodeficiency Virus) patients treated with Atazanavir containing antiretroviral regimen in the dose of 300 mg once daily. However, little is known ab...